Use of Vaccines to Prevent Meningitis in Persons with Cochlear Implants

What You Should Know

People with cochlear implants are more likely to get bacterial meningitis than people without cochlear implants. In addition, some people who are candidates for cochlear implants have anatomic factors that may increase their risk for meningitis. These factors include facial and cranial abnormalities, including of the temporal bone and cochlea.
The bacteria Streptococcus pneumoniae (pneumococcus) causes most cases of meningitis in people with cochlear implants.
Due to their increased risk, CDC recommends pneumococcal vaccination for people who have or are candidates for cochlear implants. Clinicians should follow the pneumococcal vaccine recommendations that apply to other groups at increased risk.
Recommendations for the timing and type of pneumococcal vaccination vary with age and vaccination history. See Advisory Committee on Immunization Practices (ACIP) recommendations highlighted in the box to the right for details.

Pneumococcal Vaccine Recommendations by Age and Vaccination History

Children who have or are candidates for cochlear implants may need pneumococcal vaccination. It depends on their age and which pneumococcal vaccines they have already received.

Pneumococcal vaccination is recommended for adults who have or are candidates for cochlear implants.

See Pneumococcal Vaccination: Summary of Who and When to Vaccinate for a comprehensive breakdown of recommendations by age, risk condition, and vaccination history.

Download the PneumoRecs VaxAdvisor Mobile App for Vaccine Providers for help determining which pneumococcal vaccines a patient needs and when.

On This Page

What You Should Know
Pneumococcal Recommendations by Age and Vaccination History
Other Vaccines Can Help Protect Against Meningitis
For More Information
References

ACIP Pneumococcal Vaccine Recommendations

Other Vaccines Can Help Protect Against Meningitis

There is no evidence people with cochlear implants are more likely to get Haemophilus influenzae type b (Hib) meningitis or meningococcal meningitis than people who do not have cochlear implants. However, Hib and meningococcal vaccines are routinely recommended based on age and other risk factors.

The following Hib and meningococcal vaccines are available in the United States:
- Hib conjugate (ActHIB^®, Hiberix^®, PedvaxHIB^®, Pentacel^®, and Vaxelis^®)
- Meningococcal conjugate (Menactra^®, MenQuadfi^®, and Menveo^®)
- Serogroup B meningococcal (Bexsero^® and Trumenba^®)
See Vaccine-specific ACIP Recommendations for information about how, when, and which pneumococcal, Hib, and meningococcal vaccines can be given together.

For More Information

Kahue CN, Sweeney AD, Carlson ML, Haynes DS. Vaccination recommendations and risk of meningitis following cochlear implantation. Curr Opin Otolaryngol Head Neck Surg. 2014;22(5):359–66.
Lalwani AK and Cohen NL. Does meningitis after cochlear implantation remain a concern in 2011? Otol Neurotol. 2012;33(1):93–5.
Lalwani AK and Cohen NL. Longitudinal risk of meningitis after cochlear implantation associated with the use of the positioner. Otol Neurotol. 2011;32(7):1082–5.
Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998-2007. N Engl J Med. 2011;364(21):2016–25.
Cohen NL and Hirsch BE. Current status of bacterial meningitis after cochlear implantation. Otol Neurotol. 2010;31(8):1325–8.
Rubin LG, Papsin B, Committee on Infectious Diseases and Section on Otolaryngology-Head and Neck Surgery. Cochlear implants in children: surgical site infections and prevention and treatment of acute otitis media and meningitis. Pediatrics. 2010;126:381.
Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360(3):244–56.
Mancini P, D’Elia C, Bosco E, et al. Follow-up of cochlear implant use in patients who developed bacterial meningitis following cochlear implantation. Laryngoscope. 2008;118(8):1467–71.
Biernath KR, Reefhuis J, Whitney CG, et al. Bacterial meningitis among children with cochlear implants beyond 24 months after implantation. Pediatrics. 2006:117;2:284–89.
Wilson-Clark SD, Squires S, Deeks S, Centers for Disease Control and Prevention (CDC). Bacterial meningitis among cochlear implant recipients–Canada, 2002. MMWR Morb Mortal Wkly Rep. 2006;55(Suppl 1):20.
Cohen N, Ramos A, Ramsden R, et al. International consensus on meningitis and cochlear implants. Acta Otolaryngol. 2005;125:916.
Cohen NL, Roland JT Jr, Marrinan M. Meningitis in cochlear implant recipients: the North American experience. Otol Neurotol. 2004;25(3):275–81.
Nadol JB Jr Eddington DK. Histologic evaluation of the tissue seal and biologic response around cochlear implant electrodes in the human. Otol Neurotol. 2004;25(3):257–62.
Reefhuis J, Honein M, Whitney C, et al. Risk of bacterial meningitis in children with cochlear implants. N Engl J Med. 2003:349;5:435–45.

Top of Page